Gene: ABCB9
Official Full Name: ATP binding cassette subfamily B member 9provided by HGNC
Gene Summary: The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance as well as antigen presentation. This family member functions in the translocation of peptides from the cytosol into the lysosomal lumen. Alternative splicing of this gene results in distinct isoforms which are likely to have different substrate specificities. [provided by RefSeq, Jul 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29288 | ABCB9 Knockout cell line (HeLa) | Human | ABCB9 | 1:3~1:6 | Negative | Online Inquiry |
KO29289 | ABCB9 Knockout cell line (HCT 116) | Human | ABCB9 | 1:2~1:4 | Negative | Online Inquiry |
KO29290 | ABCB9 Knockout cell line (HEK293) | Human | ABCB9 | 1:3~1:6 | Negative | Online Inquiry |
KO29291 | ABCB9 Knockout cell line (A549) | Human | ABCB9 | 1:3~1:4 | Negative | Online Inquiry |
ABCB9 Gene Knockout Cell Lines are genetically modified cell lines in which the ATP-binding cassette sub-family B member 9 (ABCB9) gene has been inactivated or "knocked out." These cell lines serve as powerful tools for studying the functional roles of ABCB9 in cellular processes such as drug transport, metabolism, and oncogenesis. By silencing this crucial gene, researchers can investigate the consequences of ABCB9 deficiency on cell behavior, including alterations in drug sensitivity and metabolic pathways.
The mechanism behind ABCB9 involves its role as a membrane protein responsible for the transport of various substrates across cellular membranes, particularly in the context of lipid metabolism and drug pharmacokinetics. By utilizing these knockout cell lines, scientists can explore the downstream effects of ABCB9 absence, allowing for a deeper understanding of its involvement in drug interactions, cellular homeostasis, and implications in diseases such as cancer.
In research and clinical settings, these cell lines are invaluable for drug discovery and development, particularly in evaluating the efficacy and safety of novel therapeutics. They enable researchers to model conditions where ABCB9 may play a pivotal role, facilitating high-throughput screening and optimization of drugs that are substrates of this transporter.
The advantages of ABCB9 Gene Knockout Cell Lines over traditional wild-type models are substantial. They offer precise insights into gene function and the phenotypic consequences of its loss, enabling more targeted and relevant research outcomes. This specificity can lead to a reduction in the time and cost associated with drug development, providing a strategic edge for researchers.
For investigators focused on the field of pharmacology, toxicology, and cancer biology, ABCB9 Gene Knockout Cell Lines represent an essential resource for advancing scientific knowledge and therapeutic innovations. Our company is committed to providing high-quality biological products and has a long-standing reputation for excellence in genetic engineering and cell line development, positioning us as a trusted partner in your research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.